Method for analyzing haemoglobin by capillary electrophoresis, a kit for capillary electrophoresis, and use of a flow inhibitor in said method
The invention concerns a method for free solution capillary electrophoresis at an alkaline pH to analyze samples comprising haemoglobin, in which the sample is passed through a capillary containing an analysis buffer, comprising at least one step in which the sample is introduced into a capillary tube containing a solution of analysis buffer, characterized in that the buffer is of the zwitterionic type and in that it is associated with at least one flow inhibitor. It also concerns the use of CE flow inhibitors associated with at least one zwitterionic buffer, and a kit for analyzing haemoglobin by capillary electrophoresis.
1. A free solution capillary electrophoresis method for separating and resolving haemoglobins in a biological sample by capillary electrophoresis, said biological sample being a blood sample, said method comprising:
introducing said biological sample into a capillary tube comprising a solution of an analysis buffer, wherein said analysis buffer is of the zwitterionic type and at least one flow inhibitor, and
electrophoresing said biological sample in said analysis buffer and at least one said flow inhibitor, whereby said haemoglobins are separated by migration, and wherein said haemoglobins are a haemoglobin HbA2 and an HbC, an HbD, an HbE, an HbS, an HbF or an HbA haemoglobin.
2. The method according to claim 1 , further comprising detecting said haemoglobins.
3. The method according to claim 1 , wherein the zwitterionic buffer is formed by one or two molecules and comprises at least one amine function, at least one acid function and at least one hydroxyl function in the position opposite to the acid function.
4. The method according to claim 1 , wherein said at least one flow inhibitor is of an aliphatic or a cyclic diamine or a polyamine type.
5. The method according to claim 1 , wherein said at least one flow inhibitor is selected from the group consisting of aliphatic diamines, aliphatic polyamines, their acceptable derivatives and salts, and mixtures thereof.
6. The method according claim 1 , wherein said analysis buffer has a concentration in said analysis buffer solution from about 20 mM to about 500 mM.
7. The method according to claim 1 , wherein said analysis buffer has a concentration in said analysis buffer solution from about 100 mM to about 250 mM.
8. The method according to claim 1 , wherein said at least one flow inhibitor has a concentration from about 0.01 mM to about 50 mM in said analysis buffer solution.
9. The method according to claim 1 , wherein said at least one flow inhibitor has a concentration from about 0.10 mM to about 20 mM in said analysis buffer solution.
10. The method according to claim 1 , wherein said capillary tube is naked.
11. The method according to claim 1 , wherein said capillary tube is formed from fused silica.
12. The method according to claim 1 , wherein said analysis buffer solution has a pH from about 8 to about 10.
13. The method according to claim 1 , wherein said blood sample is selected from the group consisting of normal blood, abnormal blood, washed blood, decanted blood, centrifuged blood haemolyzed blood, and whole blood.
14. The method according to claim 13 , wherein said blood sample is a sample of haemolyzed blood.
15. The method according to claim 1 , wherein said analysis buffer is selected from tricine, TAPS, TABS, AMPSO, bicine or HEPBS, or an association of Tris, AMPD or bis Tris propane with an amino acid.
16. The method according to claim 15 , wherein said analysis buffer is tricine.
17. The method according to claim 1 , wherein said analysis buffer solution further comprises a pH modifier.
18. The method according to claim 17 , wherein said pH modifier is selected from the group consisting of lithium hydroxide, sodium hydroxide, potassium, hydroxide, rubidium hydroxide, caesium hydroxide, francium hydroxide, mono-alkylammonium hydroxide, di-alkylammonium hydroxide, tri-alkylammonium hydroxide and tetra-alkylammonium hydroxide said alkylammonium hydroxide containing 1 to 8 carbon atoms in the alkyl portion.
19. The method according to claim 1 , wherein said an least one flow inhibitor is selected from the group consisting of 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, diethylenetriamine, spermine, N,N′-dimethyl-1,6-hexanediamine, tetraethylenepentamine, N,N,N′,N′-tetramethyl-1,4-butanediamine, their acceptable derivatives and salts, and mixtures thereof.
20. The method according to claim 19 , wherein said at least one flow inhibitor is selected from the group consisting of 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, diethylenetriamine and N,N,N′,N′-tetramethyl-1,4-butanediamine, their acceptable derivatives and salts, and mixtures thereof.
21. The method according to claim 20 , wherein said at least one flow inhibitor is 1,4-diaminobutane.
22. The method according to claim 21 , wherein said at least one flow inhibitor is 1,4-diaminobutane in the hydrochloride form.
23. A free solution capillary electrophoresis method for separating and resolving haemoglobins in a biological sample by capillary electrophoresis, said biological sample being a blood sample, said sample being selected from the group consisting of normal blood, abnormal blood, washed blood, decanted blood, centrifuged blood, whole blood and haemolyzed blood, said method comprising:
introducing said biological sample into a capillary tube comprising a solution of an analysis buffer, wherein said analysis buffer is of the zwitterionic type and at least one flow inhibitor, and
electrophoresing said biological sample in said analysis buffer and at least one said flow inhibitor, whereby said haemoglobins are separated by migration.
24. A free solution capillary electrophoresis method for separating and resolving haemoglobins in a biological sample by capillary electrophoresis, said biological sample being a blood sample, said method comprising:
introducing said biological sample into a capillary tube comprising a solution of an analysis buffer, wherein said analysis buffer is of the zwittenionic type and at least one flow inhibitor, said flow inhibitor being an aliphatic or a cyclic diamine or a polyamine type, and
electrophoresing said biological sample in said analysis buffer and at least one said flow inhibitor, whereby said haemoglobins are separated by migration.